DRUG RESEARCH GROUP INC (EIN 042763124) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

SUSAN JICK

Phone

7818626660

Tax Period

2024-07-01 to 2025-06-30

DRUG RESEARCH GROUP INC, founded in 1981, is a community nonprofit in the Health Care sector that reported $1.2M in total revenue in fiscal year 2024. Revenue surged 109% from the prior year, signaling strong growth momentum. The organization ran a surplus of $402K, a strong 34% operating margin.

Mission

RESEARCH TO PROVIDE QUANTITATIVE DATA ON THE FREQUENCY OF SIDE EFFECTS TO ALL MARKETED AND OVER THE COUNTER DRUGS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $483,680

Program Service Revenue $0

Investment Income $705,361

Other Revenue $0

TOTAL REVENUE $1,189,041

Expense Breakdown

Grants Paid $0

Salaries & Benefits $535,306

Fundraising Expenses $0

Program Expenses $725,178

Other Expenses $251,489

TOTAL EXPENSES $786,795

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,189,041	$569,545	+1.1%
Expenses	$786,795	$815,349	0.0%
Net Income	$402,246	$-245,804	-2.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$158,914

Total Directors

$71,499

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
THEODORE COLTON	DIRECTOR	20.00	Director	$0	$0	$0
LAURA E DERBY	DIRECTOR	20.00	Director	$0	$0	$0
MARIANNE ULCICKAS YOOD	DIRECTOR	20.00	Director	$0	$0	$0
KATRINA W HAGBERG	DIRECTOR	40.00	Director	$71,499	$0	$71,499
KATHLEEN MCMAHON JICK	DIRECTOR	20.00	Director	$0	$0	$0
MICHAEL J HORTON	TREASURER/CLERK	40.00	Officer	$73,104	$0	$73,104
SUSAN JICK	PRESIDENT	20.00	Officer	$85,810	$0	$85,810

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,189,041	$786,795	$1,046,880	$402,246
2024	$569,545	$815,349	$607,287	$-245,804
2023	$576,423	$997,184	$879,306	$-420,761
2022	$255,612	$996,850	$1,272,221	$-741,238
2021	$1,085,400	$966,555	$2,097,680	$118,845
2020	$1,048,653	$981,977	$1,885,378	$66,676
2019	$1,211,993	$1,048,988	$1,845,874	$163,005
2018	$1,300,835	$1,043,559	$1,733,197	$257,276

DRUG RESEARCH GROUP INC